Correlation of ANXA1 expression with drug resistance and relapse in bladder cancer

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 9, 2014, Pages 5538-5548

  Yu, Shuliang ^a   Meng, Qian ^a   Hu, Huihui ^a   Zhang, Man ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Annexin a1 (ANXA1); Bladder cancer; Drug resistance; Recurrence

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; LIPOCORTIN 1; TUMOR MARKER;

CANCER STAGING; DOWN REGULATION; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; TUMOR CELL LINE; TUMOR RECURRENCE; URINARY BLADDER NEOPLASMS;

ANNEXIN A1; ANTIBIOTICS, ANTINEOPLASTIC; BIOMARKERS, TUMOR; CELL LINE, TUMOR; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84911466504     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Mertens LS, Neuzillet Y, Horenblas S, van Rhijn BW. Landmarks in non-muscle-invasive bladder cancer. Nat Rev Urol 2014; [Epub ahead of print].
4. Vaidya S, Lakhey M, Kc S, Hirachand S. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies. JNMA J Nepal Med Assoc 2013; 52: 475-8.
5. Mossanen M, Gore JL. The burden of bladder cancer care: direct and indirect costs. Curr Opin Urol 2014; [Epub ahead of print].
6. Jacobs BL, Lee CT, Montie JE. Bladder cancer in 2010: how far have we come ? CA Cancer J Clin 2010; 60: 244-272.
7. Barton MK. High morbidity and mortality found for high-risk, non-muscle-invasive bladder cancer. CA Cancer J Clin 2013; 63: 371-2.
8. Caron D, Maaroufi H, Michaud S, Tanguay RM, Faure RL. Annexin A1 is regulated by domains cross-talk through post-translational phosphorylation and SUMOYlation. Cell Signal 2013; 25: 1962-9.
9. Guo C, Liu S, Sun MZ. Potential role of Anxa1 in cancer. Future Oncol 2013; 9: 1773-93.
10. Meng Q, Lei T, Zhang M, Zhao J, Zhao XH, Zhang M. Identification of proteins differentially expressed in adriamycin-resistant (pumc-91/ADM) and parental (pumc-91)human bladder cancer cell lines by proteome analysis. J Cancer Res Clin Oncol 2013; 139: 509-19.
11. Kang WY, Chen WT, Huang YC, Su YC, Chai CY. Overexpression of annexin 1 in the development and differentiation of urothelial carcinoma. Kaohsiung J Med Sci 2012; 28: 145-50.
12. D'Acunto CW, Gbelcova H, Festa M, Ruml T. The complex understanding of Annexin A1 phosphorylation. Cell Signal 2014; 26: 173-8.
13. Hongsrichan N, Rucksaken R, Chamgramol Y, Pinlaor P, Techasen A, Yongvanit P, Khuntikeo N, Pairojkul C, Pinlaor S. Annexin A1: A new immunohistological marker of cholangiocarcinoma. World J Gastroenterol 2013; 19: 2456-65.
14. Wang C, Xiao Q, Li YW, Zhao C, Jia N, Li RL, Cao SS, Cui J, Wang L, Wu Y, Wen AD. Regulatory mechanisms of annexin-induced chemotherapy resistance in cisplatin resistant lung adenocarcinoma. Asian Pac J Cancer Prev 2014; 15: 3191-4.
15. Deng S, Wang J, Hou L, Li J, Chen G, Jing B, Zhang X, Yang Z. Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically. Oncol Lett 2013; 5: 107-112.
16. Su N, Xu XY, Chen H, Gao WC, Ruan CP, Wang Q, Sun YP. Increased expression of annexin A1 is correlated with K-ras mutation in colorectal cancer. Tohoku J Exp Med 2010; 222: 243-50.
17. Han G, Tian Y, Duan B, Sheng H, Gao H, Huang J. Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2014; 7: 751-9.
18. Kang H, Ko J, Jang SW. The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells. Biochem Biophys Res Commun 2012; 423: 188-94.
19. Zhu DW, Yang X, Yang CZ, Ma J, Liu Y, Yan M, Wang LZ, Li J, Zhang CP, Zhang ZY, Zhong LP. Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathological differentiation grade. Oral Oncol 2013; 49: 542-50.
20. Zhang ZQ, Li XJ, Liu GT, Xia Y, Zhang XY, Wen H. Identification of Annexin A1 protein expression in human gastric adenocarcinoma using proteomics and tissuemicroarray. World J Gastroenterol 2013; 19: 7795-803.
21. Zhu F, Wang Y, Zeng S, Fu X, Wang L, Cao J. Involvement of annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study. OMICS 2009; 13: 467-76.
22. Baguley BC. Multiple drug resistance mechanisms in cancer. Mol Biotechnol 2010; 46: 308-16.
23. Maschler S, Gebeshuber CA, Wiedemann EM, Alacakaptan M, Schreiber M, Custic I, Beug H. Annexin A1 attenuates EMT and metastatic potential in breast cancer. EMBO Mol Med 2010; 2: 401-14.
24. Li KN, Jin J, Chen XG. Annexin A1 increases the sensitivity of K562 cell to imatinib. Yao Xue Xue Bao 2013; 48: 866-73.
25. de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, Kartopawiro J, Pardali E, Le Dévédec SE, Smit VT, van der Wal A, Van't Veer LJ, Cleton-Jansen AM, ten Dijke P, van de Water B. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci U S A 2010; 107: 6340-5.
26. Lim LH, Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J 2007; 21: 968-975.
27. Li CF, Shen KH, Huang LC, Huang HY, Wang YH, Wu TF. Annexin-I overexpression is associated with tumour progression and independently predicts inferior disease-specific and metastasis-free survival in urinary bladder urothelial carcinoma. Pathology 2010; 42: 43-9.
28. Zeng GQ, Cheng AL, Tang J, Li GQ, Li MX, Qu JQ, Cao C, Liao L, Xiao ZQ. Annexin A1: a new biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Med Hypotheses 2013; 81: 68-70.